Quality care measures for children proving difficult to quantify

Article

Born almost 3 years ago, the set of federal measures for quality care for children in Medicaid and CHIP is being slowly pushed out of infancy; however, states are having difficulties gathering and reporting data, which may keep some of the measures aspirational for some time.

Recent Videos
David Turkewitz, MD
H. Westley Phillips, MD
David Turkewitz, MD
Rakesh Jain, MD, MPH
Rakesh Jain, MD, MPH
Paul Helmuth, MD
Brittany Bruggeman, MD
Octavio Ramilo
Melissa Fickey, MD
Related Content
CDC confirms H5N1 bird flu infection in California childLatest revision | Image Credit: © MdBabul - © MdBabul - stock.adobe.com.

CDC confirms H5N1 bird flu infection in California child

Joshua Fitch, Senior Editor
November 22nd 2024
Article

Reportedly, the child experienced mild symptoms and has received flu antivirals.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Gildeuretinol for Stargardt disease receives Rare Pediatric Disease, Fast Track Designations | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

Gildeuretinol for Stargardt disease receives Rare Pediatric Disease, Fast Track Designations

Joshua Fitch, Senior Editor
November 22nd 2024
Article

Currently, there are no treatments for the serious, rare pediatric disease.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Paul Kruszka, MD, MPH, FACMG

Background on whole genome sequencing and review of the GUARDIAN study

Joshua Fitch, Senior Editor
November 21st 2024
Article

Paul Kruszka, MD, MPH, FACMG, chief medical officer of GeneDx, joined us to provide background of whole genome sequencing and its benefits.

New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older | Image Credit: © SNAB - © SNAB - stock.adobe.com.

New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older

Joshua Fitch, Senior Editor
November 20th 2024
Article

Once-daily icotrokinra versus placebo demonstrated clinically significant skin clearance in those with moderate-to-severe plaque psoriasis.

© 2024 MJH Life Sciences

All rights reserved.